Director
DIN: 08854731
Sushant Jayshing Jawak is currently associated with 2 companies in various capacities such as Designated Partner and Director. They serve as a Director at J3 CURE PHARMACEUTICALS LLP and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08854731.Sushant Jayshing Jawak has previously been associated with 1 company in roles such as Additional Director.Sushant Jayshing Jawak is currently involved in 2 different roles. Their most recent position is with WHITE ROSE SYSTEMS INDIA PRIVATE LIMITED as a Director. The first company Sushant Jayshing Jawak was appointed to as a director was J3 CURE PHARMACEUTICALS LLP. Sushant Jayshing Jawak is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Sushant Jayshing Jawak is currently associated with 2 companies in various capacities such as Designated Partner and Director. They serve as a Director at J3 CURE PHARMACEUTICALS LLP and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08854731.Sushant Jayshing Jawak has previously been associated with 1 company in roles such as Additional Director.Sushant Jayshing Jawak is currently involved in 2 different roles. Their most recent position is with WHITE ROSE SYSTEMS INDIA PRIVATE LIMITED as a Director. The first company Sushant Jayshing Jawak was appointed to as a director was J3 CURE PHARMACEUTICALS LLP. Sushant Jayshing Jawak is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
2
Male
India
Call +91 81049 46419 and we'll pull the verified contact details for you.
Current Companies (1)
Current LLPs (1)
Past Companies (1)
1y 3m 8 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| WHITE ROSE SYSTEMS INDIA PRIVATE LIMITED | Director | 23-Apr-2026 |